These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 31263828)
1. The prognostic value of CXCR4, MMP-2 and MMP-9 in tongue squamous carcinoma. Ciucă FI; Mărăşescu PC; Matei M; Florescu AM; Mărgăritescu C; Demetrian AD; Drăgan I; Dumitrescu CI Rom J Morphol Embryol; 2019; 60(1):59-68. PubMed ID: 31263828 [TBL] [Abstract][Full Text] [Related]
2. Changes in the expression of MMP2, MMP9, and ColIV in stromal cells in oral squamous tongue cell carcinoma: relationships and prognostic implications. Fan HX; Li HX; Chen D; Gao ZX; Zheng JH J Exp Clin Cancer Res; 2012 Oct; 31(1):90. PubMed ID: 23107277 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of the chemokine receptor CXCR4 and epithelial-to-mesenchymal transition in patients with squamous cell carcinoma of the mobile tongue. Albert S; Hourseau M; Halimi C; Serova M; Descatoire V; Barry B; Couvelard A; Riveiro ME; Tijeras-Raballand A; de Gramont A; Raymond E; Faivre S Oral Oncol; 2012 Dec; 48(12):1263-71. PubMed ID: 22776129 [TBL] [Abstract][Full Text] [Related]
4. Investigation of CXCR4 in squamous cell carcinoma of the tongue. Delilbasi CB; Okura M; Iida S; Kogo M Oral Oncol; 2004 Feb; 40(2):154-7. PubMed ID: 14693238 [TBL] [Abstract][Full Text] [Related]
5. The expression of CXCR4 and its relationship with matrix metalloproteinase-9/vascular endothelial growth factor in esophageal squamous cell cancer. Lu CL; Ji Y; Ge D; Guo J; Ding JY Dis Esophagus; 2011 May; 24(4):283-90. PubMed ID: 21087342 [TBL] [Abstract][Full Text] [Related]
6. Expression of tissue inhibitor of matrix metalloproteinase-2 correlates with activation of matrix metalloproteinase-2 and predicts poor prognosis in tongue squamous cell carcinoma. Yoshizaki T; Maruyama Y; Sato H; Furukawa M Int J Cancer; 2001 Jan; 95(1):44-50. PubMed ID: 11241310 [TBL] [Abstract][Full Text] [Related]
7. Expression of MMP-9, TIMP-1, CD-34 and factor-8 as prognostic markers for squamous cell carcinoma of the tongue. Guttman D; Stern Y; Shpitzer T; Ulanovski D; Druzd T; Feinmesser R Oral Oncol; 2004 Sep; 40(8):798-803. PubMed ID: 15288834 [TBL] [Abstract][Full Text] [Related]
8. Predictive value of laminin-5 and membrane type 1-matrix metalloproteinase expression for cervical lymph node metastasis in T1 and T2 squamous cell carcinomas of the tongue and floor of the mouth. Kawano K; Yanagisawa S Head Neck; 2006 Jun; 28(6):525-33. PubMed ID: 16619276 [TBL] [Abstract][Full Text] [Related]
9. Immunoexpression of matrix metalloproteinase-2 and matrix metalloproteinase-9 in the metastasis of squamous cell carcinoma of the human tongue. Zhou CX; Gao Y; Johnson NW; Gao J Aust Dent J; 2010 Dec; 55(4):385-9. PubMed ID: 21174909 [TBL] [Abstract][Full Text] [Related]
10. [Effect of curcumin on invasion and migration of tongue squamous cell carcinoma cell line Tca8113]. Wang WX; Sun SZ; Guo XL; Song Y Zhonghua Kou Qiang Yi Xue Za Zhi; 2008 Feb; 43(2):101-4. PubMed ID: 18683733 [TBL] [Abstract][Full Text] [Related]
11. The role of MMP-2 and MMP-9 as prognostic markers in the early stages of tongue squamous cell carcinoma. Aparna M; Rao L; Kunhikatta V; Radhakrishnan R J Oral Pathol Med; 2015 May; 44(5):345-52. PubMed ID: 25212455 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of c-Met promotes invasion and metastasis of small oral tongue carcinoma. Lim YC; Han JH; Kang HJ; Kim YS; Lee BH; Choi EC; Kim CH Oral Oncol; 2012 Nov; 48(11):1114-9. PubMed ID: 22704061 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of MMP-2, -9 and TIMP-1,-2 immunoreactive protein at the invasive front in advanced head and neck squamous cell carcinomas. Ondruschka C; Buhtz P; Motsch C; Freigang B; Schneider-Stock R; Roessner A; Boltze C Pathol Res Pract; 2002; 198(8):509-15. PubMed ID: 12389993 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of MMP-9 and VEGF in squamous cell carcinoma of the tongue. Henriques AC; de Matos FR; Galvão HC; Freitas Rde A J Oral Sci; 2012 Mar; 54(1):105-11. PubMed ID: 22466894 [TBL] [Abstract][Full Text] [Related]
15. Scutellarin inhibits the growth and invasion of human tongue squamous carcinoma through the inhibition of matrix metalloproteinase-2 and -9 and αvβ6 integrin. Li H; Huang D; Gao Z; Chen Y; Zhang L; Zheng J Int J Oncol; 2013 May; 42(5):1674-81. PubMed ID: 23546449 [TBL] [Abstract][Full Text] [Related]
16. CXCR4 promotes oral squamous cell carcinoma migration and invasion through inducing expression of MMP-9 and MMP-13 via the ERK signaling pathway. Yu T; Wu Y; Helman JI; Wen Y; Wang C; Li L Mol Cancer Res; 2011 Feb; 9(2):161-72. PubMed ID: 21205837 [TBL] [Abstract][Full Text] [Related]
17. Critical roles of Wnt5a-Ror2 signaling in aggressiveness of tongue squamous cell carcinoma and production of matrix metalloproteinase-2 via ΔNp63β-mediated epithelial-mesenchymal transition. Sakamoto T; Kawano S; Matsubara R; Goto Y; Jinno T; Maruse Y; Kaneko N; Hashiguchi Y; Hattori T; Tanaka S; Kitamura R; Kiyoshima T; Nakamura S Oral Oncol; 2017 Jun; 69():15-25. PubMed ID: 28559016 [TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase-3β mediated regulation of matrix metalloproteinase-9 and its involvement in oral squamous cell carcinoma progression and invasion. Pramanik KK; Nagini S; Singh AK; Mishra P; Kashyap T; Nath N; Alam M; Rana A; Mishra R Cell Oncol (Dordr); 2018 Feb; 41(1):47-60. PubMed ID: 29134466 [TBL] [Abstract][Full Text] [Related]
19. Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma. Patel BP; Shah PM; Rawal UM; Desai AA; Shah SV; Rawal RM; Patel PS J Surg Oncol; 2005 May; 90(2):81-8. PubMed ID: 15844188 [TBL] [Abstract][Full Text] [Related]
20. The interplay of matrix metalloproteinase-8, transforming growth factor-β1 and vascular endothelial growth factor-C cooperatively contributes to the aggressiveness of oral tongue squamous cell carcinoma. Åström P; Juurikka K; Hadler-Olsen ES; Svineng G; Cervigne NK; Coletta RD; Risteli J; Kauppila JH; Skarp S; Kuttner S; Oteiza A; Sutinen M; Salo T Br J Cancer; 2017 Sep; 117(7):1007-1016. PubMed ID: 28772283 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]